An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

Clinical trial NCT04770220 · COMPLETED

Trial details

NCT number: NCT04770220
Sponsor: Alzheon Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Early Alzheimer's Disease

Start date: 2021-05-19
Primary completion: 2024-05-29
Enrollment: 325

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.